Global Blood Therapeutics, Inc.
GBT was delisted on the 4th of October, 2022.
68 hedge funds and large institutions have $470M invested in Global Blood Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 10 closing their positions.
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
15% more funds holding
Funds holding: 59 → 68 (+9)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
58% less capital invested
Capital invested by funds: $1.12B → $470M (-$648M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$30.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.6M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$12.9M |
| 5 |
DM
Deerfield Management
New York
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$13.4M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.24M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.81M |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$4.99M |
| 5 |
Morgan Stanley
New York
|
-$3.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Tudor Investment Corp
Stamford,
Connecticut
| – | -$346K | -8,200 | Closed |
|
77
Barclays
London,
United Kingdom
| – | -$68K | -1,620 | Closed |
|
78
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$17K | -400 | Closed |
|
GBT Hedge Fund Activity: Q4 2015 in Review
68 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q4 2015, worth a combined $470M — down 58% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new GBT positions and 10 closed out — a net gain of 10 holders — while 27 added to existing stakes and 17 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $30.3M. The largest seller was RS Investment Management, exiting entirely with an estimated $13.4M sold.
- 68 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q4 2015, up from 59 in Q3 2015.
- Funds reported $470M of Global Blood Therapeutics, Inc. stock for Q4 2015, down 58% quarter-over-quarter.
- 20 funds opened new Global Blood Therapeutics, Inc. positions in Q4 2015 and 10 closed out, a net change of +10 holders.
- The largest Global Blood Therapeutics, Inc. buyer in Q4 2015 was Janus Henderson Investors US, an estimated $30.3M added.
- The largest Global Blood Therapeutics, Inc. seller in Q4 2015 was RS Investment Management, an estimated $13.4M sold.
Based on aggregated 13F filings for Q4 2015.